Ardent Health reports Q4 EPS 81c, consensus 46c

Reports Q4 revenue $1.606B, consensus $1.48B. “We had a strong finish to 2024, highlighted by reported revenue growth of 19% and Adjusted EBITDA growth of well over 200% in the fourth quarter,” stated Marty Bonick, President and Chief Executive Officer of Ardent Health (ARDT). “For the full-year 2024, we grew revenue 10%, increased Adjusted EBITDA 58%, and expanded Adjusted EBITDA margins 260 basis points. Importantly, we achieved a key milestone when the New Mexico state directed payment program was retroactively approved in November 2024 for the period covering the second half of 2024.”